Filters
Effect and pharmacokinetics of methotrexate in the treatment of psoriasis (IZ2960)
FR - Farmakologie a lékárnická chemie
- 1995 - 1997 •
- 1 473 tis. Kč •
- 1 373 tis. Kč •
- MZ
Řešení projektu: 1. 1. 1995 - 1. 1. 1997
Uznané náklady
Podpora ze státního rozpočtu (93%)
Poskytovatel: Ministerstvo zdravotnictví
Changes in the microbiome composition as a risk factor in the development of psoriasis (NV15-30782A)
Affecting 2-3% of population, psoriasis is a chronic, autoimmune skin disease that involves dysregulated interplay between immune cells, keratinocytes and environmental triggers. We hypothesize that skin microbiome composition is the crucial aspect f...
FO - Dermatovenerologie
- 2015 - 2018 •
- 6 426 tis. Kč •
- 6 426 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2015 - 31. 12. 2018
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Personalized medicine approach based on analysis of immunity and microbiota interactions as a tool to predict therapeutic response in patients with psoriasis (NW24-06-00509)
Psoriasis is a chronic, systemic immune-mediated disease with complex pathogenesis and multiple comorbidities. Current evidence suggests that a combination of genetic and environmental factors, such as obesity, stress, and microbiota composition, can...
Dermatology and venereal diseases
- 2024 - 2027 •
- 11 273 tis. Kč •
- 11 273 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2024 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
The effect of anti IL-17 therapy on skin and gut microbiota and intestinal barrier function in psoriasis patients (NU22J-05-00056)
IL-17 inhibitors have recently emerged as effective and safe therapy for the treatment of severe psoriasis with a very rapid onset of action. Although IL-17 inhibitor therapy is considered safe, its use in psoriasis treatment has been occasionally as...
Immunology
- 2022 - 2025 •
- 6 524 tis. Kč •
- 6 524 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2022 - 31. 12. 2025
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 4 out of 4